1. Home
  2. PFX vs WHWK Comparison

PFX vs WHWK Comparison

Compare PFX & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFX
  • WHWK
  • Stock Information
  • Founded
  • PFX 2010
  • WHWK 2007
  • Country
  • PFX United States
  • WHWK United States
  • Employees
  • PFX N/A
  • WHWK N/A
  • Industry
  • PFX Finance: Consumer Services
  • WHWK Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFX Finance
  • WHWK Health Care
  • Exchange
  • PFX Nasdaq
  • WHWK Nasdaq
  • Market Cap
  • PFX 100.3M
  • WHWK 82.4M
  • IPO Year
  • PFX N/A
  • WHWK N/A
  • Fundamental
  • Price
  • PFX $49.31
  • WHWK $1.72
  • Analyst Decision
  • PFX
  • WHWK
  • Analyst Count
  • PFX 0
  • WHWK 0
  • Target Price
  • PFX N/A
  • WHWK N/A
  • AVG Volume (30 Days)
  • PFX 1.0K
  • WHWK 88.0K
  • Earning Date
  • PFX 08-06-2025
  • WHWK 08-07-2025
  • Dividend Yield
  • PFX 2.89%
  • WHWK N/A
  • EPS Growth
  • PFX N/A
  • WHWK N/A
  • EPS
  • PFX 3.06
  • WHWK N/A
  • Revenue
  • PFX $23,958,590.00
  • WHWK $21,596,000.00
  • Revenue This Year
  • PFX $10.51
  • WHWK $49.83
  • Revenue Next Year
  • PFX N/A
  • WHWK N/A
  • P/E Ratio
  • PFX $16.19
  • WHWK N/A
  • Revenue Growth
  • PFX 15.02
  • WHWK N/A
  • 52 Week Low
  • PFX $44.56
  • WHWK $1.21
  • 52 Week High
  • PFX $57.40
  • WHWK $3.81
  • Technical
  • Relative Strength Index (RSI)
  • PFX 45.79
  • WHWK N/A
  • Support Level
  • PFX $49.35
  • WHWK N/A
  • Resistance Level
  • PFX $50.35
  • WHWK N/A
  • Average True Range (ATR)
  • PFX 0.12
  • WHWK 0.00
  • MACD
  • PFX 0.03
  • WHWK 0.00
  • Stochastic Oscillator
  • PFX 5.04
  • WHWK 0.00

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About WHWK Whitehawk Therapeutics Inc. Common Stock

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Share on Social Networks: